We've found
184,457
clinical trials
We've found
184,457
clinical trials
Type 2 Diabetes Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Type 2 Diabetes Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Amyotrophic Lateral Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Solid and Hematological Malignancies Clinical Trial
Updated: 12/31/1969
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 8/1/2016
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials

Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 8/1/2016
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials

Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 8/1/2016
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials

Lymphedema Clinical Trial
Updated: 12/31/1969
Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device (PCD)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Lymphedema Clinical Trial
Updated: 12/31/1969
Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device (PCD)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Spinal Cord Injury Clinical Trial
Updated: 10/24/2017
The Canadian Multicentre CSF Monitoring and Biomarker Study
Status: Enrolling
Updated: 10/24/2017
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/31/1969
MarginProbe® System U.S. Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Severe Postpartum Depression Clinical Trial
Updated: 5/26/2016
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
Status: Enrolling,
Phase
II
Updated: 5/26/2016
Click here to add this to my saved trials

Her2 Positive Breast Cancer Clinical Trial
Updated: 12/31/1969
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Her2 Positive Breast Cancer Clinical Trial
Updated: 12/31/1969
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Prostate Cancer Clinical Trial
Updated: 4/1/2016
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials

Prostate Cancer Clinical Trial
Updated: 4/1/2016
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials

Prostate Cancer Clinical Trial
Updated: 4/1/2016
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials

Prostate Cancer Clinical Trial
Updated: 4/1/2016
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Genetic Testing Clinical Trial
Updated: 12/31/1969
Prospective Registry of Multiplex Testing (PROMPT)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatitis C, Chronic Clinical Trial
Updated: 8/10/2016
A Study of the Pharmacokinetics of MK-3682 and MK-8408 in Participants With Moderate and Severe Hepatic Insufficiency (MK-3682-029)
Status: Enrolling,
Phase
I
Updated: 8/10/2016
Click here to add this to my saved trials

Hepatitis C, Chronic Clinical Trial
Updated: 8/10/2016
A Study of the Pharmacokinetics of MK-3682 and MK-8408 in Participants With Moderate and Severe Hepatic Insufficiency (MK-3682-029)
Status: Enrolling,
Phase
I
Updated: 8/10/2016
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Matched Targeted Therapy For High-Risk Leukemias and MDS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Atrial Fibrillation Clinical Trial
Updated: 12/31/1969
aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Duchenne Muscular Dystrophy Clinical Trial
Updated: 2/16/2018
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 2/16/2018
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials

Spinal Cord Injury Clinical Trial
Updated: 12/31/1969
AIH-induced Walking Recovery After Subacute SCI
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Asthma Clinical Trial
Updated: 3/14/2016
A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma
Status: Enrolling,
Phase
I
Updated: 3/14/2016
Click here to add this to my saved trials

Asthma Clinical Trial
Updated: 3/14/2016
A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma
Status: Enrolling,
Phase
I
Updated: 3/14/2016
Click here to add this to my saved trials

Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Updated: 12/31/1969
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

RLS Clinical Trial
Updated: 12/31/1969
An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Schizophrenia Clinical Trial
Updated: 12/31/1969
Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Alvocidib Biomarker-driven Phase 2 AML Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Musculoskeletal, Rheumatology Clinical Trial
Updated: 12/31/1969
Regenerex Tibial Tray Multi-Center Data Collection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

AMD Clinical Trial
Updated: 12/31/1969
Post-Approval Study of the Implantable Miniature Telescope
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
